The full report is titled “Pegylated Interferon-α2a With or Without Low-Dose Ribavirin for Treatment-Naive Patients With Hepatitis C Virus Genotype 1 Receiving Hemodialysis. A Randomized Trial.” It is in the 3 December 2013 issue of Annals of Internal Medicine (volume 159, pages 729-738). The authors are C.H. Liu, C.F. Huang, C.J. Liu, C.Y. Dai, C.C. Liang, J.F. Huang, P.H. Hung, H.B. Tsai, M.K. Tsai, S.I. Chen, J.W. Lin, S.S. Yang, T.H. Su, H.C. Yang, P.J. Chen, D.S. Chen, W.L. Chuang, M.L. Yu, and J.H. Kao.
Pegylated Interferon With or Without Ribavirin for Patients With Hepatitis C Receiving Hemodialysis. Ann Intern Med. 2013;159:I–14. doi: https://doi.org/10.7326/0003-4819-159-11-201312030-00001
Download citation file:
Published: Ann Intern Med. 2013;159(11):I-14.
Gastroenterology/Hepatology, Infectious Disease, Liver Disease, Nephrology, Renal Replacement Therapy.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use